Zhejiang Yaguang Technology Co.,Ltd. (SHA:603282)
China · Delayed Price · Currency is CNY 13.81
+0.19 (1.40%)
At close: Jul 31, 2026
SHA:603282 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 779.82 | 872.57 | 801.48 | 975.07 | 916.18 | 483.91 |
Revenue Growth | 2.02% | 8.87% | -17.80% | 6.43% | 89.33% | 15.66% |
Gross Profit Gross Profit Growth | 224.3 | 244.46 | 259.96 | 302.14 | 315.68 | 180.28 |
Operating Income Operating Income Growth | 63.2 | 95.04 | 94.49 | 168.68 | 180.38 | 102.78 |
Net Income Net Income Growth | 66.14 | 95.92 | 102.04 | 161.42 | 167.6 | 93.6 |
Earnings Per Share EPS Growth | 0.47 | 0.72 | 0.76 | 1.29 | 1.67 | 0.93 |
EPS Growth | -26.59% | -5.26% | -41.09% | -22.75% | 79.57% | 10.71% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Energy Saving and Environmental Protection Energy Saving and Environmental Protection Growth | 590.09 |
Medical Machinery Medical Machinery Growth | 269.56 |
Total Total Growth | 859.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 482.15 | 544.41 | 480.73 | 525.96 | 222.6 | 163.87 |
Total Debt Total Debt Growth | 3.41 | 3.4 | 6.31 | 3.49 | 16.92 | 17.81 |
Net Cash (Debt) Net Cash Growth | 478.74 | 541.02 | 474.42 | 522.48 | 205.68 | 146.06 |
Net Cash Growth | 10.14% | 14.04% | -9.20% | 154.03% | 40.82% | 25.89% |
Net Cash Per Share Net Cash Per Share Growth | 3.40 | 4.06 | 3.53 | 4.18 | 2.05 | 1.45 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 143.98 | 197.39 | 119.75 | -11.48 | 116.61 | 74.87 |
Capital Expenditures CapEx Growth | -60.03 | -78.88 | -114.75 | -118.18 | -93.59 | -71.76 |
Free Cash Flow Free Cash Flow Growth | 83.95 | 118.52 | 5 | -129.66 | 23.01 | 3.12 |
Free Cash Flow Growth | 46.48% | 2272.08% | - | - | 638.66% | -91.08% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.76% | 28.02% | 32.44% | 30.99% | 34.46% | 37.26% |
Operating Margin | 8.10% | 10.89% | 11.79% | 17.30% | 19.69% | 21.24% |
Pretax Margin | 10.03% | 12.66% | 14.27% | 18.75% | 20.41% | 21.99% |
Profit Margin | 8.48% | 10.99% | 12.73% | 16.55% | 18.29% | 19.34% |
FCF Margin | 10.77% | 13.58% | 0.62% | -13.30% | 2.51% | 0.64% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.230 | 0.230 | 0.235 | 0.670 |
Dividend Per Share Growth | -2.13% | -2.13% | -64.92% | - |
Dividend Yield | 1.67% | 1.18% | 1.66% | 2.73% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 29.40 | 27.40 | 19.07 | 21.42 | - | - |
P/FCF Ratio | 21.79 | 22.17 | 389.42 | - | - | - |
PS Ratio | 2.35 | 3.01 | 2.43 | 3.55 | - | - |